logo
Sign in

FLASKWORKS, LLC

Boston, MA · Founded 2016 · Biotech · Acquired

Closed-system bioreactor for automated manufacturing of personalized dendritic cell immunotherapies

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Headquarters
Boston, MA
Founded
2016
Latest Form D
$750K, Oct 2018
Total capital
$2M
Federal grants
$1.3M
3 awards · 2018–2019
Rank in peer group#7 of 12
Private capital raised
$750K
1 Form D · last Oct 2018
96 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
19
21 pending · first 2020
Rank in peer group#1 of 12

Capital timeline

20182019FEDERAL ↑EQUITY ↓Cumulative $2M$225K$294K$750K1st Form D$750K
20182019FEDERAL ↑EQUITY ↓Cumulative $2M$225K$294K$750K1st Form D$750K

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II: Automated Closed Systems for Manufacturing Autologous Dendritic Cell Therapies$750K
  • Private capital raisedForm D · SEC · 1st filing$750K
  • Federal grantHealth and Human S · Phase I · Bioactive Surface Engineering for High Yield Manufacturing of Dendritic Cell-Based Cancer Therapeutics$294K
  • Federal grantNSF · Phase I · SBIR Phase I: Automated Closed Systems for Manufacturing Autologous Dendritic Cell Therapies$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

4months

from FLASKWORKS, LLC’s first federal award to its first private round.

First federal award · Jul 2018
NSF · $225K
First Form D · Oct 2018
$750K · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Standing among 12 peers

Line = median

Biotech · System

  • Federal grantsBelow median
  • Granted patents#1 · top 8%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Shashi MurthyResearcherDirectorLinked by 10 patents
  • Jennifer RossiResearcherExecutive OfficerLinked by $1.3M in grants as PI

What it has protected

USPTO · 19 granted of 40
Show all 40 patent records

Related companies, and why

  • FLASKWORKSShares a founder: JENNIFER ROSSI
  • Nutcracker TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • Vertex PharmaceuticalsSimilar federal contract value in Biotech · null in contracts
  • Q-State Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
  • MBF THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
  • CG OncologySimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .